Why is "Fibrosis" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-21 10:54:03
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Fibrosis entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-21 and was most recently seen on 2026-03-21.
Wikipedia Overview
Fibrosis, also known as fibrotic scarring, is the development of fibrous connective tissue in response to an injury. Fibrosis can be a normal connective tissue deposition or excessive tissue deposition caused by a disease.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis - Medscape
-
Celea Therapeutics Will Present Phase 3 Trial Design for Idiopathic Pulmonary Fibrosis and Key Insights from a Deupirfenidone Drug-Drug Interaction Study at the Upcoming European Respiratory Society (ERS) Congress - BioSpace
-
Lupin Wins Ruling on Vertex Patents for Cystic Fibrosis Drug - Bloomberg Law News
-
Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis - Nature
-
Japan approves Brinsupri as first treatment for non-cystic fibrosis bronchiectasis - AllSci
-
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease - PR Newswire
-
PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) Congress - Business Wire
-
Spit It Out program empowers CF community to share personal stories - Cystic Fibrosis News Today
-
A practical toolbox for modelling fibrosis in vitro - Nature
-
Brainomix to Present Five New Studies at ERS Congress Demonstrating the Potential of Quantitative CT in Interstitial Lung Disease (ILD) - Morningstar
-
Early CF Therapy Improves Olfaction in Young Children - Medscape
-
Female Sex, Fibrosis Tied to Serious Arrhythmias in Mitral Valve Prolapse - TCTMD.com
-
Genetic testing changes care for pulmonary fibrosis patients - Mayo Clinic News Network
-
GRI Bio will present four sets of data on a potential lung-scarring treatment at ERS 2026 - Stock Titan
-
Kampo Medicine May Ease Age-Related Fat Scarring - Mirage News
-
Two drugs synergize, may help cystic fibrosis, Stanford Medicine-led study shows - Stanford Medicine
-
Researchers chart a genetic path to diagnosing pulmonary fibrosis and predicting outcomes - Mayo Clinic News Network
-
Progress in research in pulmonary fibrosis - Nature
-
Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study - Nature
-
Dietary intervention with Cordyceps sinensis suppresses pulmonary fibrosis via gut–lung axis regulation and TLR4/MyD88/Nrf2 signaling - Nature
-
Discovery of lung protein offers hope for pulmonary fibrosis - News-Medical
-
Elastokines are potentially associated with a poor prognosis in idiopathic pulmonary fibrosis - Nature
-
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis - The New England Journal of Medicine
-
Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets - Nature
-
Fibrosis at the Crossroads of Tissue Homeostasis and Cancer Workshop - National Cancer Institute (.gov)
-
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis - Science | AAAS
-
Familial Pulmonary Fibrosis Linked to Faster Lung Function Decline, UIP Pattern - The American Journal of Managed Care
-
Dietary intake and BCAA metabolism regulate pulmonary fibrosis through KDM4A-mediated epigenetic remodeling in male mice - Nature
-
The Significance of Fibrosis Patterns in Combined Pulmonary Fibrosis and Emphysema: Insights and Challenges - RSNA Journals
-
Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study - The Lancet
-
Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy - Nature
-
Conserved Transcriptional Circuits Regulate Cardiac Fibroblast-Mediated Fibrosis - American Heart Association Journals
-
She breathes life into the fight against pulmonary fibrosis - VCU News
-
Targeting macrophages in liver fibrosis - Frontiers
-
GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026 - The Manila Times
-
LepR+ Fibroblasts in Maladaptive Cardiac Fibrosis: Mechanisms and Controversies - American Heart Association Journals
-
Pulmonary fibrosis: new drug slows and reverses lung scarring - Drug Target Review
-
Developing a vaccine strategy to prevent the progression of pulmonary fibrosis - Nature
-
Treatment options for idiopathic pulmonary fibrosis (IPF) - Mayo Clinic Press
-
Leptin Receptor Fibroblasts Are Preferential Contributors to Cardiac Fibrosis - American Heart Association Journals
-
Micro(nano)plastics in the Development of Myocardial Fibrosis: From Clinical Detection to Molecular Mechanism - American Heart Association Journals
-
Biomarkers of pulmonary fibrosis in bronchoalveolar lavage fluid and saliva. Study methods and pathophysiological significance - Frontiers
-
Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis - PR Newswire
-
Winnipeggers walk for pulmonary fibrosis awareness - CTV News
-
Idiopathic Pulmonary Fibrosis (IPF) : Ron and Maxine’s Story - Boehringer Ingelheim
-
Exploring the potential of the latest treatment for pulmonary fibrosis - Boehringer Ingelheim
-
Regulated Cell Death in Idiopathic Pulmonary Fibrosis - Pan - 2026 - Wiley & Sons
-
Uncovering repurposed medicines to fight liver fibrosis - Google DeepMind
-
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study - The Lancet
-
Blocking two proteins reverses lung scarring in preclinical study - Virginia Tech News
-
Searching for a Cure for Pulmonary Fibrosis - Yale School of Medicine
-
Mechanisms of Tissue Fibrosis - Nature
-
With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate - Fierce Biotech
-
Rosmarinic acid alleviates bleomycin-induced pulmonary fibrosis in mice by activating the Rap1 pathway - Nature
-
Retroperitoneal fibrosis - The Lancet
-
The 80th at 80: UK patient crosses milestone for cystic fibrosis - UKNow
-
Nerandomilast (Jascayd) approved to treat adult patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis - GOV.UK
-
Promising results for a drug in development to treat Idiopathic Pulmonary Fibrosis - IDIBELL – Institut d'Investigació Biomèdica de Bellvitge
-
Stem Cell Biologist Andrea Alber Works to Help Those with Pulmonary Fibrosis - Boston University
-
A cure for cystic fibrosis - Radcliffe Department of Medicine
-
Decoding macrophage heterogeneity in the pulmonary fibrosis lung cancer transition - Frontiers
-
Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition - Nature
-
Global perspective on pulmonary fibrosis: epidemiology, regional variations, gaps in care and future directions - thorax.bmj.com
-
‘He will be sorely missed by everyone’ - tributes paid to former Snowman Rally champion who competed after lung transplant - Ross-shire Journal
-
Fibroblasts as regulators of lung immunity, repair and fibrosis - Nature
-
Cancer-related fibrosis : Journal of Dr. NTR University of Health Sciences - Ovid
-
Versican expression from lung fibroblasts suppresses pulmonary fibrosis - Nature
-
Viscoelastic hydrogel primed CAR-macrophage for pulmonary fibrosis treatment - Nature
-
Human iPSC-based Modeling of Pulmonary Fibrosis Reveals p300/CBP Inhibition Suppresses Alveolar Transitional Cell State - Nature
-
TGFBI promotes liver fibrosis through remodeling the profibrotic microenvironment by a positive feedback regulatory loop - Nature
-
Parathyroid hormone–related protein is a therapeutic target in idiopathic pulmonary fibrosis - Nature
-
Emerging concepts and novel mechanisms in organ fibrosis - Nature
-
New hope for patients with idiopathic pulmonary fibrosis - Michigan Medicine
-
Treatments for idiopathic pulmonary fibrosis are on the horizon - Nature
-
A nanosystem targeting tissue inhibitor of metalloproteinase-1 for continuous spatiotemporal idiopathic pulmonary fibrosis therapy - Nature
-
Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation - Science | AAAS
-
Interstitial (Nonidiopathic) Pulmonary Fibrosis: Background, Pathophysiology, Etiology - Medscape
-
Reversing Fibrosis: New Research Provides Insight for Novel Therapies - Yale School of Medicine
-
Challenging the Assumption That Fibrosis Can’t Be Reversed - The University of North Carolina at Chapel Hill
-
New Study Reveals Key Signaling Pathway in Pulmonary Fibrosis - Yale School of Medicine
-
Targeted lung Lactobacillus johnsonii intervention alleviates virus-induced fibrosis post-HCT through PD-L1/PD-1 signaling - Science | AAAS
-
RIPK3 Orchestrates Scar‐Associated Macrophage Dysfunction to Drive Pulmonary Fibrosis - Wiley & Sons
-
Combined pulmonary fibrosis and emphysema: a narrative review - Frontiers
-
Rubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis - Nature
-
Establishment of a humanized mouse model of pulmonary fibrosis for advancing drug validation strategies - Nature
-
What’s new in treating MASH and liver fibrosis? - VCU Health
-
Living Fully with Cystic Fibrosis: One Woman’s Story - American Lung Association
-
Sex-related susceptibility to pulmonary fibrosis development in mice - British Pharmacological Society | Journals
-
Idiopathic Pulmonary Fibrosis (IPF): Background, Pathophysiology, Etiology - Medscape
-
The interplay of ferroptosis and oxidative stress in pulmonary fibrosis: from mechanisms to treatment - Frontiers
-
Noninvasive Assessment of Liver Fibrosis - The New England Journal of Medicine
-
Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis - Nature
-
A mesothelial differentiation gateway drives fibrosis - Nature
-
Fernando Martinez leading nationwide DOD clinical study targeting idiopathic pulmonary fibrosis - UMass Chan Medical School
-
Revealing Causes and Possible Treatments for Fibrosis - Cedars-Sinai
-
Epithelial–mesenchymal transition in pulmonary fibrosis: molecular mechanisms and emerging therapeutic strategies - Frontiers
-
Molecular Pathways and Cellular Players in the Resolution of Organ Fibrosis - The New York Academy of Sciences
-
Multidisciplinary Approach to Familial Pulmonary Fibrosis | RadioGraphics - RSNA Journals
-
Rethinking inhaled therapies for pulmonary fibrosis - CORDIS | European Commission
-
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial - The Lancet
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.